Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Empire Metals, KEFI Gold and Copper, Ananda Pharma, ANGLE - Small Cap Snapshot

Empire Metals, KEFI Gold and Copper, Ananda Pharma, ANGLE - Small Cap Snapshot

Empire Metals Ltd (AIM:EEE, OTCQB:EPMLF) has reported high-grade titanium results from drilling at the Pitfield Project in Western Australia. All 85 holes hit broad zones of mineralisation, with standout grades reaching up to 18% TiO₂.

KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) has confirmed BCM Group is joining the Tulu Kapi project in Ethiopia, committing $23 million toward pre-production costs. KEFI now says its full development budget is covered, with major works expected to launch soon.

Ananda Pharma Plc (AQSE:ANA, OTCQB:ANANF) has got the green light from Australia's Therapeutic Goods Administration to start its first clinical trial for its CBD drug MRX1. The study will focus on how the drug moves through the body and check its safety.

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has revealed strong new data for its HER2-CTC blood test, showing over 98% accuracy at spotting HER2-positive cancer cells. The company says the test could replace invasive biopsies and help more patients access targeted treatments.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK